dactinomycin has been researched along with vidarabine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bancroft, WH; Lemon, SM | 1 |
Nagano, H; Oguro, M | 1 |
Chubb, S; Ford, R; Hittelman, WN; Meyn, RE; Plunkett, W; Robertson, LE; Story, M | 1 |
Al-Katib, A; Gabrilove, JL; König, A; Lynen, S; Menzel, T; Raveche, E; Rosén, A; Wrazel, L | 1 |
Baran-Marszak, F; Bornkamm, GW; Fagard, R; Feuillard, J; Gachard, N; Le Clorennec, C; May, E; Najjar, I; Reminieras, L; Youlyouz-Marfak, I | 1 |
Denk, U; Egle, A; Greil, R; Hamacher, F; Hofbauer, JP; Kenner, L; Kocher, T; Melchardt, T; Merkel, O; Scheideler, M; Schlederer, M; Sifft, E; Steurer, M; Wacht, N | 1 |
1 review(s) available for dactinomycin and vidarabine
Article | Year |
---|---|
[Inhibitor of eukaryotic DNA synthesis].
Topics: Acyclovir; Animals; Cytarabine; Dactinomycin; DNA Replication; Eukaryotic Cells; Humans; Mice; Nucleic Acid Synthesis Inhibitors; Rats; Vidarabine | 1983 |
8 other study(ies) available for dactinomycin and vidarabine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Lack of specific effect of adenine arabinoside, human interferon, and ribavirin on in vitro production of hepatitis B surface antigen.
Topics: Amino Acids; Antiviral Agents; Cell Line; Dactinomycin; Dose-Response Relationship, Drug; Hepatitis B Surface Antigens; Humans; Interferons; Radioimmunoassay; Ribavirin; Ribonucleosides; RNA; Vidarabine | 1979 |
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine.
Topics: Adenosine Triphosphate; Apoptosis; Cladribine; Cycloheximide; Dactinomycin; DNA, Neoplasm; Egtazic Acid; Guanosine Triphosphate; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Microscopy, Electron; Puromycin; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Uridine Triphosphate; Vidarabine | 1993 |
Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
Topics: Apoptosis; B-Lymphocytes; Cell Line, Transformed; Dactinomycin; DNA Fragmentation; Fibroblast Growth Factor 2; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Vidarabine | 1997 |
Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Brefeldin A; Cell Line, Tumor; Cisplatin; Dactinomycin; Doxorubicin; Humans; Imatinib Mesylate; Interferons; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-mdm2; Pyrimidines; STAT1 Transcription Factor; Tumor Suppressor Protein p53; Vidarabine | 2008 |
Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Dactinomycin; Female; Flow Cytometry; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Mice, Transgenic; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Survival Rate; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vidarabine | 2012 |